These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 9129959)

  • 1. Use of computer simulation to evaluate a putative cluster of genetic or teratologic outcomes: adjustment for "multiple hypotheses" and application to a reported excess of Down's syndrome.
    Hook EB; Carothers AD
    Genet Epidemiol; 1997; 14(2):133-45. PubMed ID: 9129959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Down's syndrome in Sweden during the years 1968-1977.
    Lindsten J; Marsk L; Berglund K; Iselius L; Ryman N; Annerén G; Kjessler B; Mitelman F; Nordenson I; Wahlström J; Vejlens L
    Hum Genet Suppl; 1981; 2():195-210. PubMed ID: 6218136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects.
    Jaques AM; Collins VR; Haynes K; Sheffield LJ; Francis I; Forbes R; Halliday JL
    J Med Screen; 2006; 13(1):8-13. PubMed ID: 16569299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down's syndrome: case-control study.
    Czeizel AE; Puhó E
    Nutrition; 2005 Jun; 21(6):698-704; discussion 774. PubMed ID: 15925294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input.
    Reynolds T; Ellis A; Jones R
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):464-8. PubMed ID: 15588435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: "parity and the risk of Down's syndrome".
    Clementi M; Bianca S; Tenconi R
    Am J Epidemiol; 2004 Sep; 160(6):610; author reply 611. PubMed ID: 15353424
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester combined screening for Down syndrome and other fetal anomalies.
    O'Leary P; Breheny N; Dickinson JE; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Obstet Gynecol; 2006 Apr; 107(4):869-76. PubMed ID: 16582125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the Hungarian Birth Defects Registry for surveillance, research and intervention.
    Siffel C; Czeizel AE
    Cent Eur J Public Health; 1997 Jun; 5(2):79-81. PubMed ID: 9208163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Children and adolescents with Down syndrome in Sør-Trøndelag 1978-97].
    Vik T; Borthne K; Johansen OJ
    Tidsskr Nor Laegeforen; 1999 Oct; 119(25):3743-6. PubMed ID: 10574051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experiences of women who decided to continue the pregnancy after diagnosis of Down's syndrome].
    Tijmstra TJ; Bosboom GJ; Bouman K
    Ned Tijdschr Geneeskd; 2000 Oct; 144(44):2104-7. PubMed ID: 11103672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrences of free trisomy 21: analysis of data from the National Down Syndrome Cytogenetic Register.
    Morris JK; Mutton DE; Alberman E
    Prenat Diagn; 2005 Dec; 25(12):1120-8. PubMed ID: 16231400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies.
    Morris JK; Wald NJ
    J Med Screen; 2007; 14(1):5-7. PubMed ID: 17362564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.